Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Igm Biosciences Inc
(NQ:
IGMS
)
16.54
-0.46 (-2.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Igm Biosciences Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
Today 16:31 EDT
Via
Benzinga
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
Today 16:01 EDT
From
IGM Biosciences, Inc.
Via
GlobeNewswire
Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move
September 18, 2024
Small-cap stocks are surging ahead of the expected interest rate cut by the Federal Reserve, outperforming their larger-cap counterparts. However, potential for gains may be hindered by sluggish...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
September 10, 2024
From
IGM Biosciences, Inc.
Via
GlobeNewswire
The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
September 05, 2024
Via
Benzinga
What 4 Analyst Ratings Have To Say About IGM Biosciences
August 15, 2024
Via
Benzinga
In-Depth Examination Of 6 Analyst Recommendations For IGM Biosciences
May 24, 2024
Via
Benzinga
IGMS Stock Earnings: IGM Biosciences Misses EPS, Misses Revenue for Q2 2024
August 14, 2024
IGMS stock results show that IGM Biosciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
August 14, 2024
From
IGM Biosciences, Inc.
Via
GlobeNewswire
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
July 12, 2024
The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-than-expected June inflation data and potential interest rate cuts.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 11, 2024
Via
Benzinga
What 5 Analyst Ratings Have To Say About IGM Biosciences
April 18, 2024
Via
Benzinga
IGM Biosciences to Present at the Jefferies Healthcare Conference
May 29, 2024
From
IGM Biosciences, Inc.
Via
GlobeNewswire
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 22, 2024
Via
Benzinga
Where IGM Biosciences Stands With Analysts
March 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 22, 2024
Via
Benzinga
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
May 22, 2024
Via
Benzinga
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 20, 2024
Via
Benzinga
IGMS Stock Earnings: IGM Biosciences Meets EPS, Misses Revenue for Q1 2024
May 08, 2024
IGMS stock results show that IGM Biosciences met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 08, 2024
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
May 07, 2024
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences Announces Refocusing of Sanofi Collaboration
April 17, 2024
Agreement focuses on immunology/inflammation, aligning with Sanofi’s ongoing commitment to advancing therapies for patients across multiple inflammatory diseases
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
April 10, 2024
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGMS Stock Earnings: IGM Biosciences Beats EPS, Misses Revenue for Q4 2023
March 07, 2024
IGMS stock results show that IGM Biosciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 07, 2024
From
IGM Biosciences, Inc.
Via
GlobeNewswire
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
February 12, 2024
U.S. stocks were mixed, with the Nasdaq Composite trading almost flat on Monday. Shares of CymaBay Therapeutics, Inc. (NASDAQ: CBAY) rose sharply in today’s pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 12, 2024
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and...
Via
Benzinga
RBC Capital's Rating Upgrade Propels IGM Biosciences Into Immunology Limelight
February 09, 2024
IGM Biosciences' strategic shift to immunology with promising bispecific drug, imvotamab. RBC Capital upgraded stock to Outperform, anticipating $21 price target. Data expected in 2H 2024 validates its...
Via
Benzinga
SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday
February 09, 2024
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 09, 2024
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.